Floatz logo

Hpc, Cord Blood

Acute Leukemia in Remission

Alla KeyznerCell therapyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

60 Active assets in the Acute Leukemia in Remission cohort.

Asset / SponsorPhaseRating
Fludarabine
Sawa Ito, MD
Phase 2/3BB
Cyclophosphamide
Sawa Ito, MD
Phase 4BB
Cytosin-Arabinosid
Janssen Research & Development, LLC
Phase 2/3BB
METHOTREXATE
SWOG Cancer Research Network
Phase 3BB
Busulphan
Sawa Ito, MD
Phase 4BB

View all 50 →

Same molecule, other indications

Hpc, Cord Blood is also rated in:

acute lymphoblastic leukemiaDormant
B
Indicative ·
60 / 100
View asset →
myelodysplastic syndromeDormant
CCC
Indicative ·
55 / 100
View asset →
non-Hodgkin lymphomaDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →